Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6174892
Reference Type
Journal Article
Title
Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing
Author(s)
Gascoyne, RD; Jones, S; Karsan, A; Laskin, J; Li, Y; Marra, M; Moore, R; Parker, JDK; Pleasance, E; Savage, KJ; Schein, JE; Shen, Y; Wegrzyn-Woltosz, J; Weng, AP; Zhao, Y
Year
2016
Volume
2
Issue
2
Page Numbers
1
DOI
10.1101/mcs.a000679
URL
https://search.proquest.com/docview/1808653257?accountid=171501
Exit
Abstract
In an attempt to assess potential treatment options, whole-genome and transcriptome sequencing were performed on a patient with an unclassifiable small lymphoproliferative disorder. Variants from genome sequencing were prioritized using a combination of comparative variant distributions in a spectrum of lymphomas, and meta-analyses of gene expression profiling. In this patient, the molecular variants that we believe to be most relevant to the disease presentation most strongly resemble a diffuse large B-cell lymphoma (DLBCL), whereas the gene expression data are most consistent with a low-grade chronic lymphocytic leukemia (CLL). The variant of greatest interest was a predicted NOTCH2-truncating mutation, which has been recently reported in various lymphomas.
Keywords
Biotechnology and Bioengineering Abstracts; Chronic lymphatic leukemia; Reviews; Etiology; Immunoproliferative diseases; Data processing; Genomes; Mutation; Gene expression; B-cell lymphoma; W 30965:Miscellaneous, Reviews
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity